Please login to the form below

Not currently logged in
Email:
Password:

Ariana Pharma appoints Mariana Kuras as chief technology officer

She previously worked at Biosystems International and Pfizer

Ariana Pharma has appointed former Pfizer scientist Marian Kuras as the company's chief technology officer.

She will lead technological efforts at the French firm, which provides clinical data analysis services to pharma companies to identify best patient responders, identify patients at risk of adverse events and to remove bias from trials.

Prior to joining Ariana, Dr Kuras spent eight years at French biotech Biosystems International, including four as director of research.

During this period, she was responsible for the development and validation of biomarker platform technologies in several projects across therapy areas that included oncology and neurodegenerative diseases.

Previously, she was a genomics and bioinformatics scientist at Pfizer Global Research and Development in France.

Dr Kuras has serving as an independent scientific expert for the sixth and seventh framework of the European Commission.

"Ariana has become one of the most promising international players in diagnostic and personalised medicine," said Dr Kuras. "By providing a validated solution to the challenge of combining heterogenous data from multiple sources with patient characteristics, Ariana will continue to grow as industry demand continues to increase and I am looking forward to adding my experience to the Ariana effort."

24th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CreateHealth.io

We connect companies to customers through online and offline events. Our proprietary customer insight platform, and expert staff in stakeholder...

Latest intelligence

Webinar: How to conduct effective market research in emerging markets
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge....
Webinar: Uncovering hidden insights into patient compliance
...
The patient journey: Time to look beyond the physician?
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues....